Ferritin Quantitative Test

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

Product Detail

Application

C-peptide is a substance produced by the pancreas, along with insulin. Insulin is a hormone that controls the body's glucose (blood sugar) levels. Glucose is the primary source of energy for the body. If the body does not produce the appropriate amount of insulin, it may be an indication of diabetes.

 

C-peptide and insulin are released from the pancreas simultaneously and in approximately equal amounts. As a result, a C-peptide test can provide insights into the body's insulin production levels. This test can be a useful way to measure insulin levels because C-peptide tends to remain in the body for a longer duration compared to insulin.

 

The key advantage of using a C-peptide test is that it can offer a more accurate assessment of the body's insulin production capacity. Insulin itself is cleared from the bloodstream relatively quickly, making it more challenging to measure. In contrast, C-peptide has a longer half-life, providing a more reliable indicator of the pancreas's insulin-producing capabilities.

 

By analyzing C-peptide levels, healthcare providers can gain valuable information about the underlying cause of a patient's diabetes, which can inform the most appropriate treatment approach. This test can be particularly useful in differentiating between type 1 and type 2 diabetes, as well as in monitoring the progression of the disease and the effectiveness of insulin therapy.

 

In summary, the C-peptide test provides a valuable tool for healthcare professionals to assess and manage diabetes by offering insights into the body's insulin production and secretion dynamics.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.1- 40.00 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Assessment of Endogenous Insulin Production

Distinguishing Type 1 and Type 2 Diabetes

Monitoring Islet Cell Transplants

Assessment of Insulinoma

Evaluation of Hypoglycemia

 

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Covid-19 Test
COVID-19 Ag & Flu A/B Combo Self Test
COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.
Cys C Rapid Quantitative Test
Cys-C Rapid Quantitative Test
Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.
CCP Rapid Quantitative Test (Fluorescence Immunoassay)
CCP Rapid Quantitative Test (Fluorescence Immunoassay)
The Biotime CCP Rapid Quantitative Test is intended to quantify the concentration of CCP in human serum, plasma and whole blood on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of rheumatoid arthritis. -Fluorescence immunoassay -Rheumatoid arthritis For in vitro diagnostic use only. For professional use only.
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the total thyroxine 4 (TT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac isoform of TnT (hs-cTnT) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact